Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Garudafood Putra Putri Jaya Tbk. (GOOD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Garudafood Putra Putri Jaya Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Garudafood Putra Putri Jaya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Garudafood Putra Putri Jaya Tbk. trades at Rp304 (market cap 11.36T, 93K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Garudafood Putra Putri Jaya Tbk. is far larger — about 69× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 93K). Which is the better fit depends on your goals.

GOODOBAT
Market Cap
11.36T164.65B
Volume
93K187.4K
Lot
9301.87K
Turnover
28.28M44.35M
Average Price
304.13236.67
Value
28.28M44.35M
Indicative Equilibrium Price
304242
Indicative Equilibrium Volume
16500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOD
View details
OBAT
View details

About Garudafood Putra Putri Jaya Tbk.

PT Garudafood Putra Putri Jaya (the Company) was established in Indonesia based on Notarial Deed No. 21 of Dra. Selawati Halim, S.H., dated August 24, 1994 under the name of PT Garuda Putra Putri Jaya. Based on Notarial Deed No. 12 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated November 7, 2000, the Company merged with PT Tudung Putra Jaya and PT Garudafood Jaya and subsequentlychanged its name from PT Garuda Putra Putri Jaya to PT Garudafood Putra Putri Jaya based on Notarial Deed No. 44 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated August 28, 2001

Read more on GOOD

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT